Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

12 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Eligibility Autosomal Dominant Polycystic Kidney Disease NCT02250287

- 14.08.19 - 1 Formular, 1 Itemgruppe, 23 Datenelemente, 1 Sprache
Itemgruppe: Criteria
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02250287

Eligibility Kidney Diseases NCT00141037

- 02.10.16 - 1 Formular, 2 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT00141037

Eligibility Kidney Diseases NCT00707759

- 12.05.18 - 1 Formular, 2 Itemgruppen, 10 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Steroid Withdrawal in Pediatric Renal Transplant Immunosuppression : Impact on Growth, Bone Metabolism and Acute Rejection; ODM derived from: https://clinicaltrials.gov/show/NCT00707759

Eligibility Kidney Failure, Chronic NCT02011139

- 02.05.20 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Cognitive-behavioral (CBT) in ESRD Patients With Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02011139

Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease NCT00920309 - Eligibility

- 04.04.19 - 1 Formular, 2 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
This trial is designed to determine whether rapamycin is safe and effective treatment for patients with polycystic kidney disease (ADPKD). Patients will be followed by volumetric magnetic resonance imaging (MRI) to observe for change in kidney (and cyst) size. Blood and urine samples will also be collected to evaluate for change in biomarkers with treatment. ODM derived from: https://clinicaltrials.gov/show/NCT00920309

Eligibility Kidney Cancer NCT00365768

- 03.10.16 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00365768

Eligibility Polycystic Kidney, Autosomal Dominant NCT00410007

- 03.06.17 - 1 Formular, 2 Itemgruppen, 15 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00410007

Eligibility Chronic Kidney Disease NCT00395005

- 05.02.17 - 1 Formular, 2 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Correlation of Urinary Kallikrein With Cytokines, Proteinuria and Renal Function in Chronic Renal Disease Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00395005

Eligibility Polycystic Kidney Disease NCT01873235

- 21.01.21 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
PKD Clinical and Translational Core Study; ODM derived from: https://clinicaltrials.gov/show/NCT01873235

Eligibility Renal Cell Carcinoma NCT00831857

- 29.09.18 - 1 Formular, 1 Itemgruppe, 13 Datenelemente, 1 Sprache
Itemgruppe: Inclusion Criteria
VEGF Imaging in Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00831857

Eligibility Renal Cell Carcinoma NCT00631371

- 29.09.18 - 1 Formular, 2 Itemgruppen, 8 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00631371

Eligibility Renal Cell Carcinoma NCT00417677

- 28.09.18 - 1 Formular, 1 Itemgruppe, 19 Datenelemente, 1 Sprache
Itemgruppe: Criteria
A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00417677

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video